{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:01:24Z","timestamp":1790107284364,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100017050","name":"Cycle for Survival","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA008748"],"award-info":[{"award-number":["P30CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.modpat.2024.100467","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T16:37:49Z","timestamp":1709829469000},"page":"100467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Mohammed","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Fu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirma","family":"Koutzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikmat A.","family":"Al-Ahmadie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samson W.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Gopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Sarungbam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Joseph","family":"Sirintrapun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Tickoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Reuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5207-3648","authenticated-orcid":false,"given":"Ying-Bei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.modpat.2024.100467_bib1","series-title":"WHO Classification of Tumours Urinary and Male Genital Tumours","year":"2022"},{"issue":"5","key":"10.1016\/j.modpat.2024.100467_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.eururo.2022.06.016","article-title":"The 2022 World Health Organization classification of tumours of the urinary system and male genital organs\u2014part a: renal, penile, and testicular tumours","volume":"82","author":"Moch","year":"2022","journal-title":"Eur Urol"},{"issue":"9","key":"10.1016\/j.modpat.2024.100467_bib3","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41379-022-01057-z","article-title":"Do we need an updated classification of oncocytic renal tumors? Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities","volume":"35","author":"Hes","year":"2022","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100467_bib4","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41379-022-01108-5","article-title":"Low grade oncocytic tumors of the kidney: a clinically relevant approach for the workup and accurate diagnosis","volume":"35","author":"Amin","year":"2022","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100467_bib5","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.pathol.2022.09.002","article-title":"LOT and HOT or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia","volume":"54","author":"Samaratunga","year":"2022","journal-title":"Pathology"},{"issue":"2","key":"10.1016\/j.modpat.2024.100467_bib6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/his.13865","article-title":"Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?","volume":"75","author":"Trpkov","year":"2019","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.modpat.2024.100467_bib7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/PAS.0000000000001457","article-title":"Eosinophilic renal cell tumors with a TSC and MTOR gene mutations are morphologically and immunohistochemically heterogenous: clinicopathologic and molecular study","volume":"44","author":"Tjota","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100467_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.eururo.2020.03.003","article-title":"Next-generation RNA sequencing-based biomarker characterization of chromophobe renal cell carcinoma and related oncocytic neoplasms","volume":"78","author":"Skala","year":"2020","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100467_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00428-020-02927-0","article-title":"Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China","volume":"478","author":"Guo","year":"2021","journal-title":"Virchows Arch"},{"issue":"4","key":"10.1016\/j.modpat.2024.100467_bib10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00428-020-02900-x","article-title":"FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry","volume":"478","author":"Tong","year":"2021","journal-title":"Virchows Arch"},{"key":"10.1016\/j.modpat.2024.100467_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.humpath.2020.12.006","article-title":"TSC\/MTOR-mutated eosinophilic renal tumors are a distinct entity that is CK7+\/CK20-\/vimentin-: a validation study","volume":"115","author":"Tjota","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2024.100467_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2021.04.013","article-title":"Low-grade oncocytic tumor of kidney (CK7-positive, CD117-negative): incidence in a single institutional experience with clinicopathological and molecular characteristics","volume":"114","author":"Kravtsov","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.modpat.2024.100467_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2021.06.002","article-title":"Co-existence of ESC-RCC, EVT, and LOT as synchronous and metachronous tumors in six patients with multifocal neoplasia but without clinical features of tuberous sclerosis complex","volume":"116","author":"Lerma","year":"2021","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2024.100467_bib14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jclinpath-2021-207478","article-title":"Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute","volume":"75","author":"Akgul","year":"2022","journal-title":"J\u00a0Clin Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100467_bib15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/s41379-021-00906-7","article-title":"Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1","volume":"35","author":"Morini","year":"2022","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100467_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41379-021-00896-6","article-title":"Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney","volume":"35","author":"Kapur","year":"2022","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100467_bib17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00428-022-03283-x","article-title":"Low-grade oncocytic tumor of kidney harboring TSC\/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity","volume":"480","author":"Zhang","year":"2022","journal-title":"Virchows Arch"},{"issue":"11","key":"10.1016\/j.modpat.2024.100467_bib18","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/PAS.0000000000001955","article-title":"TSC\/MTOR -associated eosinophilic renal tumors exhibit a heterogeneous clinicopathologic spectrum:a targeted next-generation sequencing and gene expression profiling study","volume":"46","author":"Xia","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100467_bib19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/his.14816","article-title":"Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity","volume":"82","author":"Williamson","year":"2023","journal-title":"Histopathology"},{"key":"10.1016\/j.modpat.2024.100467_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2023.1610852","article-title":"Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations","volume":"29","author":"Chen","year":"2023","journal-title":"Pathol Oncol Res"},{"issue":"4","key":"10.1016\/j.modpat.2024.100467_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/path.1711550402","article-title":"Chromophobe cell renal carcinoma and its variants\u2014a report on 32 cases","volume":"155","author":"Thoenes","year":"1988","journal-title":"J\u00a0Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2024.100467_bib22","first-page":"356","article-title":"Specific loss of chromosomes 1, 2, 6, 10, 13, 17, and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization","volume":"145","author":"Speicher","year":"1994","journal-title":"Am J Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100467_bib23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ccr.2014.07.014","article-title":"The somatic genomic landscape of chromophobe renal cell carcinoma","volume":"26","author":"Davis","year":"2014","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.modpat.2024.100467_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/modpathol.3800286","article-title":"Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma","volume":"18","author":"Brunelli","year":"2005","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2024.100467_bib25","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3390\/cancers11101492","article-title":"Classic chromophobe renal cell carcinoma incur a larger number of chromosomal losses than seen in the eosinophilic subtype","volume":"11","author":"Ohashi","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.modpat.2024.100467_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J\u00a0Mol Diagn"},{"issue":"1","key":"10.1016\/j.modpat.2024.100467_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"D1","key":"10.1016\/j.modpat.2024.100467_bib28","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","author":"Forbes","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"16","key":"10.1016\/j.modpat.2024.100467_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkw520","article-title":"FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing","volume":"44","author":"Shen","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.modpat.2024.100467_bib30","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/PAS.0000000000001170","article-title":"Somatic mutations of TSC2 or MTOR characterize a morphologically distinct subset of sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm","volume":"43","author":"Chen","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2024.100467_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92688","article-title":"Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma","volume":"2","author":"Casuscelli","year":"2017","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.modpat.2024.100467_bib32","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/1078-0432.1190.11.3","article-title":"The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas","volume":"11","author":"Allory","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.modpat.2024.100467_bib33","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1083\/jcb.143.7.2067","article-title":"The cell adhesion molecule L1 is developmentally regulated in the renal epithelium and is involved in kidney branching morphogenesis","volume":"143","author":"Debiec","year":"1998","journal-title":"J\u00a0Cell Biol"},{"issue":"4","key":"10.1016\/j.modpat.2024.100467_bib34","first-page":"237","article-title":"The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct","volume":"56","author":"St\u00f6rkel","year":"1989","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100467_bib35","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02890016","article-title":"Intercalated cells as a probable source for the development of renal oncocytoma","volume":"56","author":"St\u00f6rkel","year":"1988","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100467_bib36","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/ijc.29658","article-title":"L1CAM in human cancer","volume":"138","author":"Altevogt","year":"2016","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2024.100467_bib37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4161\/cam.20832","article-title":"L1CAM: a major driver for tumor cell invasion and motility","volume":"6","author":"Kiefel","year":"2012","journal-title":"Cell Adh Migr"},{"key":"10.1016\/j.modpat.2024.100467_bib38","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1146\/annurev-physiol-052521-121841","article-title":"How many cell types are in the kidney and what do they do?","volume":"84","author":"Balzer","year":"2022","journal-title":"Annu Rev Physiol"},{"issue":"46","key":"10.1016\/j.modpat.2024.100467_bib39","doi-asserted-by":"crossref","first-page":"E9989","DOI":"10.1073\/pnas.1710964114","article-title":"Transcriptomes of major renal collecting duct cell types in mouse identified by single-cell RNA-seq","volume":"114","author":"Chen","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.modpat.2024.100467_bib40","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.celrep.2017.07.043","article-title":"Cell-type-specific gene programs of the normal human nephron define kidney cancer subtypes","volume":"20","author":"Lindgren","year":"2017","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.modpat.2024.100467_bib41","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.eururo.2018.06.007","article-title":"Somatic bi-allelic loss of TSC genes in eosinophilic solid and cystic renal cell carcinoma","volume":"74","author":"Mehra","year":"2018","journal-title":"Eur Urol"},{"issue":"7685","key":"10.1016\/j.modpat.2024.100467_bib42","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nature25023","article-title":"Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40","volume":"552","author":"Yang","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.modpat.2024.100467_bib43","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.cellsig.2014.05.011","article-title":"Recent progress in the study of the Rheb family GTPases","volume":"26","author":"Heard","year":"2014","journal-title":"Cell Signal"},{"issue":"7484","key":"10.1016\/j.modpat.2024.100467_bib44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.modpat.2024.100467_bib45","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41467-017-00933-6","article-title":"Variation in a range of mTOR-related genes associates with intracranial volume and intellectual disability","volume":"8","author":"Reijnders","year":"2017","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.modpat.2024.100467_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001279","article-title":"RHEB\/mTOR hyperactivity causes cortical malformations and epileptic seizures through increased axonal connectivity","volume":"19","author":"Proietti Onori","year":"2021","journal-title":"PLoS Biol"},{"issue":"18","key":"10.1016\/j.modpat.2024.100467_bib47","doi-asserted-by":"crossref","first-page":"12195","DOI":"10.1074\/jbc.C113.543736","article-title":"Structure-guided mutation of the conserved G3-box glycine in Rheb generates a constitutively activated regulator of mammalian target of rapamycin (mTOR)","volume":"289","author":"Mazhab-Jafari","year":"2014","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.modpat.2024.100467_bib48","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/acn3.51286","article-title":"Gradient of brain mosaic RHEB variants causes a continuum of cortical dysplasia","volume":"8","author":"Lee","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.modpat.2024.100467_bib49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"issue":"269","key":"10.1016\/j.modpat.2024.100467_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"5","key":"10.1016\/j.modpat.2024.100467_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.modpat.2024.100467_bib52","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41379-021-00737-6","article-title":"Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","volume":"34","author":"Trpkov","year":"2021","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100467_bib53","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/01913129709021939","article-title":"Diagnostic significance of mitochondria in four types of renal epithelial neoplasms: an ultrastructural study of 60 tumors","volume":"21","author":"Erlandson","year":"1997","journal-title":"Ultrastruct Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2024.100467_bib54","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00000478-199905000-00006","article-title":"Subtypes of chromophobe cell renal carcinoma: an ultrastructural and histochemical study of 13 cases","volume":"23","author":"Latham","year":"1999","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2024.100467_bib55","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1097\/00000478-200009000-00008","article-title":"Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma","volume":"24","author":"Tickoo","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100467_bib56","first-page":"275","article-title":"Intracytoplasmic lumina in a case of bilaterally multifocal renal oncocytomas","volume":"118","author":"Lyzak","year":"1994","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.modpat.2024.100467_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/019262339802600101","article-title":"Normal ultrastructure of the kidney and lower urinary tract","volume":"26","author":"Verlander","year":"1998","journal-title":"Toxicol Pathol"},{"issue":"8","key":"10.1016\/j.modpat.2024.100467_bib58","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/PAS.0000000000001288","article-title":"Papillary renal neoplasm with reverse polarity: a morphologic, immunohistochemical, and molecular study","volume":"43","author":"Al-Obaidy","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.modpat.2024.100467_bib59","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/his.14084","article-title":"Frequent KRAS mutations in oncocytic papillary renal neoplasm with inverted nuclei","volume":"76","author":"Tong","year":"2020","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.modpat.2024.100467_bib60","doi-asserted-by":"crossref","first-page":"692","DOI":"10.5858\/arpa.2022-0156-OA","article-title":"Papillary renal neoplasm with reverse polarity: a clinical, pathologic, and molecular study of 8 renal tumors from a single institution","volume":"147","author":"Nova-Camacho","year":"2023","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.modpat.2024.100467_bib61","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.humpath.2021.03.009","article-title":"Morphological, immunohistochemical, and genomic analyses of papillary renal neoplasm with reverse polarity","volume":"112","author":"Kiyozawa","year":"2021","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2024.100467_bib62","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/carcin\/bgq249","article-title":"L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells","volume":"32","author":"Doberstein","year":"2011","journal-title":"Carcinogenesis"},{"issue":"24","key":"10.1016\/j.modpat.2024.100467_bib63","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103240118","article-title":"Single-cell analyses of renal cell cancers reveal insights into tumor microenvironment, cell of origin, and therapy response","volume":"118","author":"Zhang","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.modpat.2024.100467_bib64","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PAS.0000000000002152","article-title":"Hybrid oncocytic tumors (HOTs) in Birt-Hogg-Dub\u00e9 syndrome patients-a tale of two cities: sequencing analysis reveals dual lineage markers capturing the 2 cellular populations of HOT","volume":"48","author":"Wang","year":"2024","journal-title":"Am J Surg Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224000474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395224000474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T10:21:21Z","timestamp":1746094881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395224000474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0893395224000474"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100467","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2024.100467","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100467"}}